NIVOLUMAB AND HYALURONIDASE-NVHY

NIVOLUMAB AND HYALURONIDASE-NVHY was reported 136 times

NIVOLUMAB AND HYALURONIDASE-NVHY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATOGENOUS DIABETES 1 0.0154
1 CRANIAL NERVE PARALYSIS 1 0.0021
2 INGROWN HAIR 1 0.0014
3 CRANIAL NERVE DISORDER 1 0.0014
4 PRODUCT STORAGE ISSUE 5 0.0013
5 VASCULAR CALCIFICATION 1 0.0009
6 BENIGN NEOPLASM 1 0.0009
7 EYELID SKIN DRYNESS 1 0.0008
8 ADNEXA UTERI PAIN 1 0.0008
9 ABSCESS ORAL 1 0.0007
10 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
11 PANCREATIC FAILURE 1 0.0006
12 VOCAL CORD PARALYSIS 1 0.0006
13 TONGUE BLISTERING 1 0.0004
14 PORTAL HYPERTENSION 1 0.0003
15 PRODUCT PREPARATION ISSUE 2 0.0003
16 PROTEIN TOTAL DECREASED 1 0.0003
17 THYROID FUNCTION TEST ABNORMAL 1 0.0002
18 CHAPPED LIPS 1 0.0002
19 NON-SMALL CELL LUNG CANCER 1 0.0002
20 PANCREATIC DISORDER 1 0.0002
21 POLYARTHRITIS 1 0.0002
22 SKIN ATROPHY 1 0.0002
23 ADRENAL INSUFFICIENCY 2 0.0002
24 HYPERTRANSAMINASAEMIA 1 0.0001
25 FAECES SOFT 1 0.0001
26 SENSITIVE SKIN 1 0.0001
27 PRODUCT STORAGE ERROR 11 0.0001
28 DECUBITUS ULCER 1 0.0001
29 HICCUPS 1 0.0001
30 INFUSION SITE ERYTHEMA 1 0.0001
31 SKIN SWELLING 1 0.0001
32 MYOSITIS 1 0.0001
33 PNEUMONITIS 3 0.0001
34 IRON DEFICIENCY ANAEMIA 1 0.0001
35 PRODUCT DISTRIBUTION ISSUE 1 0.0001
36 SPINAL DISORDER 1 0.0001
37 BRAIN INJURY 1 0.0001
38 FULL BLOOD COUNT DECREASED 2 0.0001
39 EYELID PTOSIS 1 0.0001
40 FOLLICULITIS 1 0.0001
41 SCRATCH 1 0.0001
42 CARDIOMEGALY 1 0.0001
43 DIPLOPIA 2 0.0001
44 SKIN LESION 2 0.0001
45 ORAL DISCOMFORT 1 0.0001
46 HYPOMAGNESAEMIA 1 0.0001
47 PARAESTHESIA ORAL 1 0.0001
48 LABORATORY TEST ABNORMAL 2 0.0001
49 HYPOAESTHESIA ORAL 1 0.0001
50 IMPAIRED HEALING 2 0.0001
51 BLOOD UREA INCREASED 1 0.0001
52 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
53 EOSINOPHILIA 1 0.0001
54 RESTLESS LEGS SYNDROME 1 0.0001
55 HEPATIC CIRRHOSIS 1 0.0001
56 DYSPNOEA EXERTIONAL 2 0.0001
57 HYPOCALCAEMIA 1 0.0001
58 PULMONARY FIBROSIS 1 0.0001
59 ACUTE RESPIRATORY FAILURE 1 0.0001
60 ERUCTATION 1 0.0001
61 HAEMORRHOIDS 1 0.0001
62 SKIN FISSURES 1 0.0001
63 PRODUCT PRESCRIBING ISSUE 1 0.0000
64 RASH MACULO-PAPULAR 1 0.0000
65 GLOSSODYNIA 1 0.0000
66 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
67 PRESYNCOPE 1 0.0000
68 OFF LABEL USE 35 0.0000
69 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
70 UNRESPONSIVE TO STIMULI 1 0.0000
71 PAIN OF SKIN 1 0.0000
72 DYSPHONIA 2 0.0000
73 HEPATIC FAILURE 1 0.0000
74 DISCOMFORT 2 0.0000
75 INJECTION SITE RASH 1 0.0000
76 ADVERSE EVENT 3 0.0000
77 NIGHT SWEATS 1 0.0000
78 LIP SWELLING 1 0.0000
79 EYE PRURITUS 1 0.0000
80 DEVICE USE ERROR 1 0.0000
81 RASH MACULAR 1 0.0000
82 RASH 12 0.0000
83 CONSTIPATION 6 0.0000
84 DYSARTHRIA 1 0.0000
85 SEIZURE 3 0.0000
86 DECREASED APPETITE 6 0.0000
87 INJECTION SITE BRUISING 2 0.0000
88 DRY MOUTH 2 0.0000
89 ARTHRALGIA 10 0.0000
90 SKIN EXFOLIATION 2 0.0000
91 MYALGIA 4 0.0000
92 HYPERHIDROSIS 3 0.0000
93 RECTAL HAEMORRHAGE 1 0.0000
94 SEPTIC SHOCK 1 0.0000
95 DRY SKIN 3 0.0000
96 OCULAR HYPERAEMIA 1 0.0000
97 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
98 PRODUCT DOSE OMISSION ISSUE 6 0.0000
99 DRY EYE 1 0.0000
100 CELLULITIS 1 0.0000
101 ILLNESS 2 0.0000
102 MUSCULOSKELETAL PAIN 1 0.0000
103 RASH PRURITIC 1 0.0000
104 URTICARIA 3 0.0000
105 BLISTER 1 0.0000
106 HYPONATRAEMIA 1 0.0000
107 BONE PAIN 1 0.0000
108 STOMATITIS 1 0.0000
109 PLEURAL EFFUSION 1 0.0000
110 INJECTION SITE ERYTHEMA 2 0.0000
111 FATIGUE 12 0.0000
112 DEEP VEIN THROMBOSIS 1 0.0000
113 SWELLING FACE 1 0.0000
114 WEIGHT DECREASED 4 0.0000
115 SLEEP DISORDER 1 0.0000
116 PAIN IN EXTREMITY 4 0.0000
117 EPISTAXIS 1 0.0000
118 UNEVALUABLE EVENT 1 0.0000
119 INJECTION SITE SWELLING 1 0.0000
120 HOSPITALISATION 2 0.0000
121 PERIPHERAL SWELLING 2 0.0000
122 INJECTION SITE HAEMORRHAGE 1 0.0000
123 CARDIAC FAILURE CONGESTIVE 1 0.0000
124 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
125 CARDIAC ARREST 1 0.0000
126 RENAL IMPAIRMENT 1 0.0000
127 MUSCULOSKELETAL STIFFNESS 1 0.0000
128 TACHYCARDIA 1 0.0000
129 GASTROINTESTINAL DISORDER 1 0.0000
130 DIARRHOEA 7 0.0000
131 OROPHARYNGEAL PAIN 1 0.0000
132 CARDIAC DISORDER 1 0.0000
133 PRURITUS 4 0.0000
134 DRUG INTOLERANCE 1 0.0000
135 HEART RATE INCREASED 1 0.0000
136 SYNCOPE 1 0.0000
137 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
138 SINUSITIS 1 0.0000
139 HAEMOGLOBIN DECREASED 1 0.0000
140 ABDOMINAL DISTENSION 1 0.0000
141 DEATH 8 0.0000
142 MUSCULAR WEAKNESS 1 0.0000
143 CHILLS 1 0.0000
144 DIZZINESS 4 0.0000
145 RENAL FAILURE 1 0.0000
146 DEHYDRATION 1 0.0000
147 MEMORY IMPAIRMENT 1 0.0000
148 MALAISE 3 0.0000
149 ACUTE KIDNEY INJURY 1 0.0000
150 NAUSEA 5 0.0000
151 ABDOMINAL DISCOMFORT 1 0.0000
152 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
153 NASOPHARYNGITIS 1 0.0000
154 ASTHENIA 2 0.0000
155 ANAEMIA 1 0.0000
156 GAIT DISTURBANCE 1 0.0000
157 ERYTHEMA 1 0.0000
158 BACK PAIN 1 0.0000
159 ABDOMINAL PAIN 1 0.0000
160 VOMITING 2 0.0000
161 FEELING ABNORMAL 1 0.0000
162 COUGH 1 0.0000
163 INJECTION SITE PAIN 1 0.0000
164 PAIN 2 0.0000
165 PYREXIA 1 0.0000
166 DYSPNOEA 1 0.0000
167 HEADACHE 1 0.0000
168 DRUG INEFFECTIVE 1 0.0000